SGMOQ · Sangamo Therapeutics, Inc · Shareholders & Ownership
Substantial doubt about the company's ability to continue as a going concern.
“Our history of significant losses, negative cash flows from operations, negative working capital, limited liquidity resources currently on hand and dependence on our ability to obtain additional financing to fund our operations have resulted in management's assessment that there is substantial doubt about our ability to continue as a going concern for at least the next 12 months from the date the financial statements included in this Quarterly Report are issued.”View the 10-Q filed May 14, 2026
Every disclosed holder of SGMOQ in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.
Who Owns SGMOQ
13F quarter Jun 30, 2026| Holder group | Shares | % Out |
|---|---|---|
| Institutional (13F) | 533,408 | 0.13% |
| Insiders (Forms 3, 4, 5) | 4,655,318 | 1.12% |
| 13D/G-only blocks | 81,948,189 | 19.78% |
| Remaining | 327,151,932 | 78.97% |
| Registered funds (N-PORT, not summed) | 621,453 | 0.15% |
Shares outstanding: 414,288,847, the issuer's latest cover-page count restated onto today's split basis.
13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.
Holders of SGMOQ
| # | Holder | Shares | As of | Notes |
|---|---|---|---|---|
| 1 |
ARMISTICE CAPITAL, LLC
13G
CIK 1601086 · Registered investment adviser · Jun 30, 2026
Rule 13d-1(b), qualified institution
|
38,860,819 | ||
| 2 |
|
14,652,466 | ||
| 3 |
|
14,095,865 | ||
| 4 |
WASATCH ADVISORS LP
13G
CIK 814133 · Registered investment adviser · Mar 31, 2025
Rule 13d-1(b), qualified institution
|
11,630,671 | ||
| 5 |
|
2,708,368 | ||
| 6 |
|
1,895,043 | ||
| 7 |
|
660,042 | ||
| 8 |
|
647,370 | ||
| 9 |
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.
13F
CIK 921739 · Investment adviser · Jun 30, 2026
|
400,000 | ||
| 9.1 |
Nomura Healthcare Fund
Fund
S000018873 · Registered fund · Jun 30, 2026
Delaware Group Equity Funds IV, not summed
|
400,000 | ||
| 10 |
Dubois-Stringfellow Nathalie
Insider
CIK 1947007 · May 25, 2026
SVP-CHIEF DEVELOPMENT OFFICER, issuer-wide
|
328,733 | ||
| 11 |
|
235,292 | ||
| 12 |
VIP Disciplined Small Cap Portfolio
Fund
S000007725 · Registered fund · Jun 30, 2026
Variable Insurance Products Fund II, not summed
|
220,038 | ||
| 13 |
|
113,654 | ||
| 14 |
|
112,600 | ||
| 15 |
|
102,100 | ||
| 16 |
|
99,600 | ||
| 17 |
|
99,600 | ||
| 18 |
|
99,600 | ||
| 19 |
|
96,384 | ||
| 20 |
|
82,650 | ||
| 21 |
|
82,650 | ||
| 22 |
SIMPLEX TRADING, LLC
13F
CIK 1488542 · Unknown · Jun 30, 2026
|
76,500 | ||
| 23 |
Axiom Investment Management LLC
13F
CIK 1513703 · Registered investment adviser · Jun 30, 2026
|
25,375 | ||
| 24 |
FLOW TRADERS U.S. LLC
13F
CIK 1466697 · Unknown · Jun 30, 2026
|
21,532 | ||
| 25 |
Heritage Investment Group, Inc.
13F
CIK 1876811 · Registered investment adviser · Jun 30, 2026
|
10,000 | ||
| 26 |
Guggenheim Active Allocation Fund
Fund
· Registered fund · May 29, 2026
Guggenheim Active Allocation Fund, not summed
|
1,415 | ||
| 27 |
BARCLAYS PLC
13F
CIK 312069 · Bank · Jun 30, 2026
|
1 |
Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.